213 related articles for article (PubMed ID: 21985151)
41. Crystal structure of the lytic CHAP(K) domain of the endolysin LysK from Staphylococcus aureus bacteriophage K.
Sanz-Gaitero M; Keary R; Garcia-Doval C; Coffey A; van Raaij MJ
Virol J; 2014 Jul; 11():133. PubMed ID: 25064136
[TBL] [Abstract][Full Text] [Related]
42. Crystallization of the CHAP domain of the endolysin from Staphylococcus aureus bacteriophage K.
Sanz-Gaitero M; Keary R; Garcia-Doval C; Coffey A; van Raaij MJ
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2013 Dec; 69(Pt 12):1393-6. PubMed ID: 24316838
[TBL] [Abstract][Full Text] [Related]
43. Preliminary treatment of bovine mastitis caused by Staphylococcus aureus, with trx-SA1, recombinant endolysin of S. aureus bacteriophage IME-SA1.
Fan J; Zeng Z; Mai K; Yang Y; Feng J; Bai Y; Sun B; Xie Q; Tong Y; Ma J
Vet Microbiol; 2016 Aug; 191():65-71. PubMed ID: 27374909
[TBL] [Abstract][Full Text] [Related]
44. Phage K
Lehman SM; Kongari R; Glass AM; Koert M; Ray MD; Plaut RD; Stibitz S
Viruses; 2022 Dec; 15(1):. PubMed ID: 36680060
[TBL] [Abstract][Full Text] [Related]
45. Characterization of a novel endolysin LysSA11 and its utility as a potent biocontrol agent against Staphylococcus aureus on food and utensils.
Chang Y; Kim M; Ryu S
Food Microbiol; 2017 Dec; 68():112-120. PubMed ID: 28800818
[TBL] [Abstract][Full Text] [Related]
46. Phage conversion of exfoliative toxin A in Staphylococcus aureus isolated from cows with mastitis.
Endo Y; Yamada T; Matsunaga K; Hayakawa Y; Kaidoh T; Takeuchi S
Vet Microbiol; 2003 Oct; 96(1):81-90. PubMed ID: 14516710
[TBL] [Abstract][Full Text] [Related]
47. Wide host range and strong lytic activity of Staphylococcus aureus lytic phage Stau2.
Hsieh SE; Lo HH; Chen ST; Lee MC; Tseng YH
Appl Environ Microbiol; 2011 Feb; 77(3):756-61. PubMed ID: 21148689
[TBL] [Abstract][Full Text] [Related]
48. Novel chimerical endolysins with broad antimicrobial activity against methicillin-resistant Staphylococcus aureus.
Fernandes S; Proença D; Cantante C; Silva FA; Leandro C; Lourenço S; Milheiriço C; de Lencastre H; Cavaco-Silva P; Pimentel M; São-José C
Microb Drug Resist; 2012 Jun; 18(3):333-43. PubMed ID: 22432707
[TBL] [Abstract][Full Text] [Related]
49. Contribution of Podoviridae and Myoviridae bacteriophages to the effectiveness of anti-staphylococcal therapeutic cocktails.
Kornienko M; Kuptsov N; Gorodnichev R; Bespiatykh D; Guliaev A; Letarova M; Kulikov E; Veselovsky V; Malakhova M; Letarov A; Ilina E; Shitikov E
Sci Rep; 2020 Oct; 10(1):18612. PubMed ID: 33122703
[TBL] [Abstract][Full Text] [Related]
50. Phage endolysins with broad antimicrobial activity against Enterococcus faecalis clinical strains.
Proença D; Fernandes S; Leandro C; Silva FA; Santos S; Lopes F; Mato R; Cavaco-Silva P; Pimentel M; São-José C
Microb Drug Resist; 2012 Jun; 18(3):322-32. PubMed ID: 22480295
[TBL] [Abstract][Full Text] [Related]
51. Isolation and characterization of a virulent bacteriophage SPW specific for Staphylococcus aureus isolated from bovine mastitis of lactating dairy cattle.
Li L; Zhang Z
Mol Biol Rep; 2014 Sep; 41(9):5829-38. PubMed ID: 24981924
[TBL] [Abstract][Full Text] [Related]
52. Bacteriophage effectively kills multidrug resistant Staphylococcus aureus clinical isolates from chronic rhinosinusitis patients.
Zhang G; Zhao Y; Paramasivan S; Richter K; Morales S; Wormald PJ; Vreugde S
Int Forum Allergy Rhinol; 2018 Mar; 8(3):406-414. PubMed ID: 29240296
[TBL] [Abstract][Full Text] [Related]
53. Isolation of a Novel Lytic Bacteriophage against a Nosocomial Methicillin-Resistant
Pertics BZ; Szénásy D; Dunai D; Born Y; Fieseler L; Kovács T; Schneider G
Biomed Res Int; 2020; 2020():5463801. PubMed ID: 33426055
[TBL] [Abstract][Full Text] [Related]
54. Efficacy of chimeric ectolysin P128 in drug-resistant Staphylococcus aureus bacteraemia in mice.
Channabasappa S; Chikkamadaiah R; Durgaiah M; Kumar S; Ramesh K; Sreekanthan A; Sriram B
J Antimicrob Chemother; 2018 Dec; 73(12):3398-3404. PubMed ID: 30215762
[TBL] [Abstract][Full Text] [Related]
55. Lysis-deficient phages as novel therapeutic agents for controlling bacterial infection.
Paul VD; Sundarrajan S; Rajagopalan SS; Hariharan S; Kempashanaiah N; Padmanabhan S; Sriram B; Ramachandran J
BMC Microbiol; 2011 Aug; 11():195. PubMed ID: 21880144
[TBL] [Abstract][Full Text] [Related]
56. Characterization of the Lytic Capability of a LysK-Like Endolysin, Lys-phiSA012, Derived from a Polyvalent Staphylococcus aureus Bacteriophage.
Fujiki J; Nakamura T; Furusawa T; Ohno H; Takahashi H; Kitana J; Usui M; Higuchi H; Tanji Y; Tamura Y; Iwano H
Pharmaceuticals (Basel); 2018 Feb; 11(1):. PubMed ID: 29495305
[TBL] [Abstract][Full Text] [Related]
57. Antibacterial Effects of Phage Lysin LysGH15 on Planktonic Cells and Biofilms of Diverse Staphylococci.
Zhang Y; Cheng M; Zhang H; Dai J; Guo Z; Li X; Ji Y; Cai R; Xi H; Wang X; Xue Y; Sun C; Feng X; Lei L; Han W; Gu J
Appl Environ Microbiol; 2018 Aug; 84(15):. PubMed ID: 29776929
[TBL] [Abstract][Full Text] [Related]
58. Restoration of sensitivity of a diverse set of drug-resistant Staphylococcus clinical strains by bactericidal protein P128.
Nair S; Poonacha N; Desai S; Hiremath D; Tuppad D; Mohan T; Chikkamadaiah R; Durgaiah M; Kumar S; Channabasappa S; Vipra A; Sharma U
J Med Microbiol; 2018 Mar; 67(3):296-307. PubMed ID: 29458674
[TBL] [Abstract][Full Text] [Related]
59. A Novel
Cater K; Dandu VS; Bari SM; Lackey K; Everett GF; Hatoum-Aslan A
mSphere; 2017; 2(2):. PubMed ID: 28357414
[TBL] [Abstract][Full Text] [Related]
60. Structural and biochemical characterization reveals LysGH15 as an unprecedented "EF-hand-like" calcium-binding phage lysin.
Gu J; Feng Y; Feng X; Sun C; Lei L; Ding W; Niu F; Jiao L; Yang M; Li Y; Liu X; Song J; Cui Z; Han D; Du C; Yang Y; Ouyang S; Liu ZJ; Han W
PLoS Pathog; 2014 May; 10(5):e1004109. PubMed ID: 24831957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
